IBC's BioProcess International™ China
 

Download Brochure


Antibody & Immunity
Market Research Antibody & Immunity Market Research

IBC's BioProcess International™ China
September 07 - 08, 2009 · The Westin Beijing Chaoyang Hotel · Beijing, China
Choose your language:   Japanese Korean Traditional Chinese Simplified Chinese

Scientific Advisory Board

Chris Z. Chen, Ph.D., Chief Operating Officer, Shanghai Celgen Biopharmaceuticals

Julius Zhiliang Li, MSc., MBA, Chief Executive Officer, AutekBio, Inc.

Shun Luo, Ph.D., Scientific Director, Cell Science & Technology ATO, Amgen Inc

Wei Wang, Ph.D., Associate Research Fellow, Global Biologics, Pfizer Inc.

Guo-Liang Yu, Ph.D., President & CEO, Epitomics Inc.

Scott Wheelwright, Ph.D., Chief Executive Officer, Strategic Manufacturing Worldwide, Inc.

Jianguo Yang, Ph.D., Scientist and Group Leader, Cell Line Development, MedImmune LLC

David (Xiaojian) Zhao, Ph.D., Technical Area Manager, Research & Development, Life Technologies

Joe Zhou, Ph.D., CEO, ShineRun BioPharma Co., Ltd., Biopharmaceutical Division of Wison Group

Copyright IBC Life Sciences, a part of Informa Life Sciences Group
Global Information, Inc. - International Marketing Partner of IBC LifeSciences.